Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio: 2011-2024

Historic Debt Ratio for Ani Pharmaceuticals (ANIP) over the last 11 years, with Dec 2024 value amounting to 0.25.

  • Ani Pharmaceuticals' Debt Ratio fell 10.62% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 10.62%. This contributed to the annual value of 0.25 for FY2024, which is 24.52% down from last year.
  • Ani Pharmaceuticals' Debt Ratio amounted to 0.25 in FY2024, which was down 24.52% from 0.33 recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Debt Ratio registered a high of 0.40 during FY2020, and its lowest value of 0.25 during FY2024.
  • For the 3-year period, Ani Pharmaceuticals' Debt Ratio averaged around 0.32, with its median value being 0.33 (2023).
  • Per our database at Business Quant, Ani Pharmaceuticals' Debt Ratio climbed by 1.21% in 2022 and then decreased by 24.52% in 2024.
  • Ani Pharmaceuticals' Debt Ratio (Yearly) stood at 0.40 in 2020, then dropped by 7.50% to 0.37 in 2021, then increased by 1.21% to 0.38 in 2022, then declined by 12.86% to 0.33 in 2023, then fell by 24.52% to 0.25 in 2024.